![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() | Targeting C3 u0026 IC Glomerulopathies Pegcetacoplan (GlomCon Foundation) View |
![]() | Pegcetacoplan in Patients With C3G and Primary IC-MPGN (CheckRare) View |
![]() | Results from a Phase 2 Trial of Pegcetacoplan in Patients With C3G and IC-MPGN (CheckRare) View |
![]() | PGNMID or C3 GN - Case discussion (GlomCon Foundation) View |
![]() | Investigational Drug Provides Improved Quality of Life for PNH Patients (CheckRare) View |
![]() | Long-Term Use of Pegcetacoplan in Patients with PNH (CheckRare) View |
![]() | C3 glomerulopathy update (WebCast Streamer) View |
![]() | KOL Interviews - Will FDA Approve Pegcetacoplan (INNOVATE RETINA) View |
![]() | Effectiveness of Pegcetacoplan, Avacincaptad Pegol in Geographic Atrophy Treatment | ASRS 2023 (Managed Healthcare Executive) View |
![]() | Apellis Eyeing 2017 Release of Phase II Results (OIS@AAO 2016) (OIS: Ophthalmology Innovation Source) View |